Answers are grounded in this paper and cite their sources.
-110 as valuable candidates for improving tetanus intrathecal therapy, where dosage is limited by cerebrospinal fluid protein tolerance.
No takes yet. Share an insight, caveat, or question.
Fabris et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: